A retrospective study to evaluate the epidemiology of Acute Pancreatitis in patients with history of immune checkpoint inhibitors use and describe underlying associations
Latest Information Update: 10 Jul 2020
At a glance
- Drugs Atezolizumab (Primary) ; Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Cancer
- Focus Adverse reactions
- 10 Jul 2020 New trial record
- 19 May 2020 Results published in Gasteroenterology in conjunction with Digestive Disease Week 2020.